Vistagen Therapeutics, Inc. (VTGN) Operating margin 2017–2026
Vistagen Therapeutics, Inc. (VTGN) operating margin by fiscal year — reported operating income divided by reported revenue.
-5683.7%FY2026 · since FY2017: -819.9% → -5683.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -5683.7% | +5833.4 pp |
| FY2025 | -11517.1% | -8413.6 pp |
| FY2024 | -3103.5% | — |
| FY2022 | -4308.3% | -2662.2 pp |
| FY2021 | -1646.1% | — |
| FY2017 | -819.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice